Intrapatient Variability of Efavirenz Concentrations as a Predictor of Virologic Response to Antiretroviral Therapy

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 979-984

  Brundage, Richard C ^a   Yong, Florence H ^b,f   Fenton, Terence ^b   Spector, Stephen A ^c   Starr, Stuart E ^d   Fletcher, Courtney V ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG MONITORING; DRUG RESPONSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAPATIENT VARIABILITY; INTRASPECIFIC VARIATION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REBOUND; SCORING SYSTEM; VIROLOGIC RESPONSE; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HIV INFECTIONS; HUMANS; MALE; OXAZINES; REGRESSION ANALYSIS; RNA, VIRAL; SURVIVAL ANALYSIS;

EID: 1442349117     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.979-984.2004     Document Type: Article

References (14)

1. Acosta, E. P., and J. G. Gerber. 2002. Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res. Hum. Retrovir. 18:825-834.
2. Acosta, E. P., K. Henry, L. Baken, L. M. Page, and C. V. Fletcher. 1999. Indinavir concentrations and antiviral effect. Pharmacotherapy 19:708-712.
3. Beal, S. L., and L. B. Sheiner. 1992. NONMEM user's guide. NONMEM Project Group, University of California-San Francisco, San Francisco.
4. Cox, D. R. 1972. Regression models and life-tables. J. R. Stat. Soc. Ser. B 34:187-213.
5. Dibley, M. J., J. B. Goldsby, N. W. Staehling, and F. L. Trowbridge. 1987. Development of normalized curves for the international growth reference: historical and technical considerations. Am. J. Clin. Nutr. 46:736-748.
6. Durant, J., P. Clevenbergh, R. Garraffo, P. Halfon, S. Icard, P. Del Giudice, N. Montagne, J. M. Schapiro, and P. Dellamonica. 2000. Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt study. AIDS 14:1333-1339.
7. Fletcher, C. V., E. P. Acosta, K. Henry, L. M. Page, C. R. Gross, S. P. Kawle, R. P. Remmel, A. Erice, and H. H. Balfour. 1998. Concentration-controlled zidovudine therapy. Clin. Pharmacol. Ther. 64:331-338.
8. Fletcher, C. V., P. L. Anderson, T. N. Kakuda, T. W. Schacker, K. Henry, C. R. Gross, and R. C. Brundage. 2002. Concentration-controlled compared with conventional antiretroviral therapy in human immunodeficiency virus infection. AIDS 16:551-560.
9. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
10. Lehmann, E. L. 1975. Nonparametrics: statistical methods based on ranks. Holden-Day, Inc., San Francisco, Calif.
11. Segal, M. R. 1997. Features of tree-structured survival analysis. Epidemiology 8:344-346.
12. Segal, M. R. 1988. Regression trees for censored data. Biometrics 44:35-47.
13. Spector, S. A., K. Hsia, F. H. Yong, S. Cabral, T. Fenton, C. V. Fletcher, J. McNamara, L. M. Mofenson, and S. E. Starr. 2000. Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children. J. Infect. Dis. 182:1769-1773.
14. Starr, S. E., C. V. Fletcher, S. A. Spector, F. H. Yong, T. Fenton, R. C. Brundage, D. Manion, N. Ruiz, M. Gersten, M. Becker, J. McNamara, L. M. Mofenson, L. Purdue, S. Siminski, B. Graham, D. M. Kornhauser, W. Fiske, C. Vincent, H. W. Lischner, W. M. Dankner, P. M. Flynn, et al. 1999. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. N. Engl. J. Med. 341:1874-1881.